Cynthia J Mcnaughton, RN-C, OHNP
Occupational Health · Mountain View
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
On the public record
- Medicare does not list them as allowed to order and refer
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Cynthia J Mcnaughton’s office at (650) 940-7021 to ask if they take your plan before you enroll.
Money from drug and device companies
$738 in 2025
| 2025 | 5 | 6 | None | $738 |
| 2024 | 4 | 4 | None | $532 |
| 2023 | 3 | 3 | None | $313 |
| 2022 | 3 | 4 | None | $419 |
| 2021 | 2 | 2 | None | $194 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Gilead Sciences | Epclusa | $234 | 2 payments
|
| Abbott Laboratories | Freestyle Libre 3 | $176 | 1 payment
|
| Otsuka Pharmaceutical Development & Commercialization | None | $112 | 1 payment
|
| Janssen Pharmaceuticals | Spravato | $109 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Fasenra | $108 | 1 payment
|
See all 6 published payments
| Gilead Sciences | Meals · 2025-09-17 | None | $127 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-08-19 | Fasenra | $108 |
| Janssen Pharmaceuticals | Meals · 2025-06-27 | Spravato | $109 |
| Abbott Laboratories | Meals · 2025-05-13 | Freestyle Libre 3 | $176 |
| Otsuka Pharmaceutical Development & Commercialization | Meals · 2025-03-13 | None | $112 |
| Gilead Sciences | Meals · 2025-02-19 | Epclusa | $106 |
See earlier years (2024, 2023, 2022, 2021)
2024: $532
| Madrigal Pharmaceuticals | Rezdiffra | $150 | 1 payment
|
| Neurocrine Biosciences | Ingrezza | $136 | 1 payment
|
| Gilead Sciences | None | $125 | 1 payment
|
| Otsuka Pharmaceutical Development & Commercialization | None | $122 | 1 payment
|
2023: $313
| Otsuka Pharmaceutical Development & Commercialization | Jynarque | $125 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $116 | 1 payment
|
| Gilead Sciences | Vemlidy | $72 | 1 payment
|
2022: $419
| Amgen | Avsola | $183 | 2 payments
|
| Vertos Medical | Mild Device Kit | $128 | 1 payment
|
| Eisai | None | $108 | 1 payment
|
2021: $194
| Amgen | Repatha | $102 | 1 payment
|
| AbbVie | Ubrelvy | $92 | 1 payment
|
Professional record
- NPI
- 1457693582
- Licence
- CA 336081
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 363LX0106X (363LX0106X)
- Mailing address
- 2500 Grant Rd, Mountain View, CA, 94040
- NPI first listed
- 2013-03-27
- NPI last updated
- 2013-03-27
This is when the NPI record was last certified, not a medical board exam.